Autonomix Medical (AMIX) investor relations material

Executive summary

• Annual Meeting scheduled for October 29, 2026, with proxy materials available online and by request, aiming to reduce environmental impact and costs.

• Shareholders of record as of September 8, 2026, are eligible to vote on four key proposals, with a quorum requirement of one-third of voting power.

• Voting can be done online, by mail, or in person, with clear procedures for proxy revocation and vote counting.

Voting matters and shareholder proposals

• Proposal 1: Election of six directors to serve until the 2027 annual meeting.

• Proposal 2: Ratification of Forvis Mazars, LLP as independent auditor for fiscal year ending March 31, 2027.

• Proposal 3: Amendment to authorize a reverse stock split at a ratio between 1-for-2 and 1-for-25, at the Board's discretion, within one year.

• Proposal 4: Approval of an amendment to the 2023 Equity Incentive Plan to increase shares authorized for issuance.

• Board recommends voting FOR all proposals.

Board of directors and corporate governance

• Board consists of six members, with four deemed independent under Nasdaq rules.

• Board committees: Audit, Compensation, and Nominating & Corporate Governance, each with independent members and defined charters.

• Board and committees held a total of 13 meetings in fiscal 2026, with high attendance.

• Policies in place include anti-hedging, insider trading, and a code of ethics.